214 related articles for article (PubMed ID: 34986868)
1. PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome.
Terra VS; Mauri M; Sannasiddappa TH; Smith AA; Stevens MP; Grant AJ; Wren BW; Cuccui J;
Microb Cell Fact; 2022 Jan; 21(1):6. PubMed ID: 34986868
[TBL] [Abstract][Full Text] [Related]
2. Multivalent poultry vaccine development using Protein Glycan Coupling Technology.
Mauri M; Sannasiddappa TH; Vohra P; Corona-Torres R; Smith AA; Chintoan-Uta C; Bremner A; Terra VS; Abouelhadid S; Stevens MP; Grant AJ; Cuccui J; Wren BW;
Microb Cell Fact; 2021 Oct; 20(1):193. PubMed ID: 34600535
[TBL] [Abstract][Full Text] [Related]
3. Modification of the Campylobacter jejuni N-linked glycan by EptC protein-mediated addition of phosphoethanolamine.
Scott NE; Nothaft H; Edwards AV; Labbate M; Djordjevic SP; Larsen MR; Szymanski CM; Cordwell SJ
J Biol Chem; 2012 Aug; 287(35):29384-96. PubMed ID: 22761430
[TBL] [Abstract][Full Text] [Related]
4. In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation.
Kämpf MM; Braun M; Sirena D; Ihssen J; Thöny-Meyer L; Ren Q
Microb Cell Fact; 2015 Jan; 14():12. PubMed ID: 25612741
[TBL] [Abstract][Full Text] [Related]
5. Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.
Ihssen J; Haas J; Kowarik M; Wiesli L; Wacker M; Schwede T; Thöny-Meyer L
Open Biol; 2015 Apr; 5(4):140227. PubMed ID: 25833378
[TBL] [Abstract][Full Text] [Related]
6. Structural insights from random mutagenesis of Campylobacter jejuni oligosaccharyltransferase PglB.
Ihssen J; Kowarik M; Wiesli L; Reiss R; Wacker M; Thöny-Meyer L
BMC Biotechnol; 2012 Sep; 12():67. PubMed ID: 23006740
[TBL] [Abstract][Full Text] [Related]
7. Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
Wetter M; Kowarik M; Steffen M; Carranza P; Corradin G; Wacker M
Glycoconj J; 2013 Jul; 30(5):511-22. PubMed ID: 23053636
[TBL] [Abstract][Full Text] [Related]
8. Investigation into the efficiency of diverse N-linking oligosaccharyltransferases for glycoengineering using a standardised cell-free assay.
Lehri B; Atkins E; Scott TA; Abouelhadid S; Wren BW; Cuccui J
Microb Biotechnol; 2024 Jun; 17(6):e14480. PubMed ID: 38858807
[TBL] [Abstract][Full Text] [Related]
9. Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.
Cuccui J; Wren B
J Pharm Pharmacol; 2015 Mar; 67(3):338-50. PubMed ID: 25244672
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design.
Terra VS; Mills DC; Yates LE; Abouelhadid S; Cuccui J; Wren BW
J Med Microbiol; 2012 Jul; 61(Pt 7):919-926. PubMed ID: 22516134
[TBL] [Abstract][Full Text] [Related]
11. Modification of avian pathogenic Escherichia coli χ7122 lipopolysaccharide increases accessibility to glycoconjugate antigens.
Smith AA; Corona-Torres R; Hewitt RE; Stevens MP; Grant AJ;
Microb Cell Fact; 2022 Sep; 21(1):181. PubMed ID: 36071433
[TBL] [Abstract][Full Text] [Related]
12. Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.
Cuccui J; Thomas RM; Moule MG; D'Elia RV; Laws TR; Mills DC; Williamson D; Atkins TP; Prior JL; Wren BW
Open Biol; 2013 May; 3(5):130002. PubMed ID: 23697804
[TBL] [Abstract][Full Text] [Related]
13. Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli.
Harding CM; Feldman MF
Glycobiology; 2019 Jul; 29(7):519-529. PubMed ID: 30989179
[TBL] [Abstract][Full Text] [Related]
14. Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines.
Kay EJ; Mauri M; Willcocks SJ; Scott TA; Cuccui J; Wren BW
Microb Cell Fact; 2022 Apr; 21(1):66. PubMed ID: 35449016
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the Campylobacter jejuni N-linked protein glycosylation pathway.
Linton D; Dorrell N; Hitchen PG; Amber S; Karlyshev AV; Morris HR; Dell A; Valvano MA; Aebi M; Wren BW
Mol Microbiol; 2005 Mar; 55(6):1695-703. PubMed ID: 15752194
[TBL] [Abstract][Full Text] [Related]
16. Advances in Bacterial Oligosaccharyltransferase Structure Elucidation and Potential Application to Glycoconjugate Vaccine Design.
Lu R; Li P; Zhu L; Chang MX; Ouyang S
Front Biosci (Landmark Ed); 2023 Nov; 28(11):305. PubMed ID: 38062836
[TBL] [Abstract][Full Text] [Related]
17. A combinatorial DNA assembly approach to biosynthesis of N-linked glycans in E. coli.
Passmore IJ; Faulds-Pain A; Abouelhadid S; Harrison MA; Hall CL; Hitchen P; Dell A; Heap JT; Wren BW
Glycobiology; 2023 Mar; 33(2):138-149. PubMed ID: 36637423
[TBL] [Abstract][Full Text] [Related]
18. Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli.
Feldman MF; Wacker M; Hernandez M; Hitchen PG; Marolda CL; Kowarik M; Morris HR; Dell A; Valvano MA; Aebi M
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3016-21. PubMed ID: 15703289
[TBL] [Abstract][Full Text] [Related]
19. Production of Vaccines Using Biological Conjugation.
Kay EJ; Terra VS
Methods Mol Biol; 2022; 2414():281-300. PubMed ID: 34784042
[TBL] [Abstract][Full Text] [Related]
20. Identification of a protein glycosylation operon from Campylobacter jejuni JCM 2013 and its heterologous expression in Escherichia coli.
Srichaisupakit A; Ohashi T; Fujiyama K
J Biosci Bioeng; 2014 Sep; 118(3):256-62. PubMed ID: 24650731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
